Comparative biodistribution of thin-coated iron oxide nanoparticles TCION: Effect of different bisphosphonate coatings

Drug Development Research

Volumn 54, Issue 4, 2001, Pages 173-181

  Portet, David ^a   Denizot, Benoît ^a,c   Rump, Elmar ^b   Hindre, François ^a   Le Jeune, Jean Jacques ^a   Jallet, Pierre ^a  

^a UPRES EA 2169   (France)

^b SANOFI   (France)

^c INSERM   (France)

Author keywords

Bone targeting; MPS; MRI; Tissular diffusion; Vascular remanence

Indexed keywords

BISPHOSPHONIC ACID DERIVATIVE; HYDROXYL GROUP; IRON 59; IRON OXIDE; NANOPARTICLE; QUATERNARY AMMONIUM DERIVATIVE; TECHNETIUM 99M;

ANIMAL EXPERIMENT; ARTICLE; BONE; CONTROLLED STUDY; DRUG COATING; DRUG DISTRIBUTION; EVALUATION; HYDRODYNAMICS; LIVER; MALE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; RAT; SURFACE CHARGE; TISSUE DISTRIBUTION;

EID: 0035725258     PISSN: 02724391     EISSN: None     Source Type: Journal    
DOI: 10.1002/ddr.10027     Document Type: Article

References (2)

1. Ahl P, Bhatia S, Meers P, Roberts P, Stevens R, Dause R, Perkins W, Janoff A. 1997. Enhancement of the in vivo circulation lifetime of distearoylphosphatidylcholine liposomes: importance of liposomal aggregation versus complement opsonization. Bioch Biophys Acta 1329:370-382.
2. Babes L, Denizot B, Tanguy G, Le Jeune JJ, Jallet E 1999. Synthesis of iron oxide nanoparticles used as MRI contrast agents: a parametric study. J Coll Interface Sci 212:474-482.